Enclomiphene vs testosterone injections: the real tradeoffs

Last updated 2026-07-27

What's actually different between enclomiphene and testosterone injections?

The mechanism is the whole story here, so it's worth getting straight before anything else. Testosterone injections (cypionate, enanthate, propionate) put exogenous hormone directly into your bloodstream. Your brain senses that testosterone level, decides you have plenty, and the hypothalamus dials back GnRH. Less GnRH means less LH and FSH from the pituitary, and LH and FSH are what actually drive the testicles to make sperm and their own testosterone. Shut those signals off long enough and the testicles idle. Size drops. Sperm counts often fall toward zero. Enclomiphene works upstream instead. It's a selective estrogen receptor modulator, specifically the trans-isomer of clomiphene citrate, and it blocks estrogen receptors at the hypothalamus ^[1]. Your brain reads that as "estrogen is low," so it keeps pushing GnRH, LH, and FSH out at normal or higher levels. The testicles get told to keep working, and testosterone rises because your own glands are making more of it, not because you injected it. That's the central tradeoff. Injections raise T fast and predictably but tend to suppress natural production and fertility. Enclomiphene raises T by working with your own axis, so testicular function and sperm production are more likely to continue. "More likely" is doing real work in that sentence, and we'll get to why below. If you want the dosing mechanics once you understand the tradeoff, see Enclomiphene Direct dosage and the Enclomiphene Direct dosage calculator.

Does enclomiphene actually preserve fertility better than TRT?

The honest answer: the mechanism strongly favors enclomiphene, and the clinical data on TRT-induced infertility is well established, but enclomiphene itself has less long-term outcome data than you'd want. On the TRT side, the evidence is clear and repeated across decades. Exogenous testosterone suppresses spermatogenesis in the large majority of men, and testosterone alone has been studied directly as a male contraceptive because suppression is so reliable ^[2]. A widely cited WHO multinational trial of injectable testosterone as contraception found it produced azoospermia (zero sperm) in most men and near-complete suppression in nearly all others ^[2]. That's not a side effect story, that's the mechanism working as designed, just aimed at fertility instead of fertility preservation. On the enclomiphene side, the logic is sound: by keeping LH and FSH intact, it should avoid that shutdown. Clinical trials of enclomiphene citrate (the Androxal development program run by Repros Therapeutics) showed it raised testosterone into the normal range while maintaining LH, FSH, and sperm parameters better than topical testosterone gel comparators in secondary hypogonadism ^[3]. That's meaningfully different from TRT's known suppression profile. But these were mid-size phase 3 trials, not large fertility-outcome studies tracking live birth rates or years-long sperm count trends, and the drug never reached FDA approval, so there's no approved label backing specific fertility claims. So: preserved fertility is the plausible, mechanism-backed expectation with enclomiphene, and it's consistent with what trial data showed for LH/FSH and semen parameters. It is not a guarantee, and nobody should market it as one.

Is enclomiphene FDA-approved, and what does that mean for what you're actually buying?

No. Enclomiphene citrate, under the brand name Androxal, went through FDA clinical trials for secondary hypogonadism but the New Drug Application never won approval, and Repros Therapeutics discontinued the program after repeated FDA responses ^[4]. There is no FDA-approved enclomiphene product on the market today. What's sold today as "enclomiphene" is a compounded drug, made by a compounding pharmacy under a prescription, not a commercially manufactured, FDA-approved medication. Compounded drugs are regulated differently than approved drugs: the FDA doesn't independently verify their safety and efficacy for a specific indication the way it does for an approved NDA, and compounders operate under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act, which governs pharmacy compounding and outsourcing facilities ^[5]. That's a materially different regulatory footing than injectable testosterone. Testosterone cypionate and enanthate, by contrast, are FDA-approved drugs with full prescribing information, established manufacturing standards, and decades on the market . That doesn't make TRT automatically "safer" in the clinical sense, it just means the regulatory pathway and quality assurance system behind the product is different. If you go the enclomiphene route, the practical question becomes which compounding pharmacy is filling the prescription and whether that pharmacy is reputable and appropriately licensed, which is a genuinely different due-diligence exercise than picking up a vial of testosterone cypionate from a standard retail pharmacy. Worth saying plainly: clomiphene citrate (brand name Clomid) is FDA-approved, but for female infertility, and clomiphene itself is a mixture of two isomers, enclomiphene (trans-clomiphene) and zuclomiphene (cis-clomiphene). Enclomiphene is the isomer thought to carry most of the anti-estrogenic, LH/FSH-boosting activity; zuclomiphene has a longer half-life and different, weakly estrogenic activity ^[1]. Isolating enclomiphene alone was the entire point of the Androxal development program, the idea being fewer estrogen-related side effects than clomiphene as a whole. So enclomiphene, clomiphene, and Clomid are related but not interchangeable, and none of the enclomiphene-only products has an approved indication for men.

How do testosterone levels, side effects, and monitoring actually compare?

Both raise testosterone, but the shape of the curve and the side effect profile differ enough to matter day to day. Injectable testosterone (especially cypionate/enanthate on a weekly or biweekly schedule) produces a peak-and-trough pattern: T levels spike a day or two after the shot, then decline until the next dose. That swing is linked to mood variability, libido swings, and more pronounced hematocrit increases in some men, which is why the FDA label for testosterone products carries a warning about polycythemia and recommends monitoring hematocrit . Estradiol also rises because testosterone aromatizes, and some men on injections need an aromatase inhibitor to manage estrogen-related side effects like water retention or gynecomastia. Enclomiphene, taken as a daily oral dose, tends to produce steadier LH/FSH-driven testosterone levels without the same injection peak-trough swing, and because it's raising testosterone through the body's own production rather than adding exogenous hormone, aromatization and estradiol elevation still happen but track more proportionally with the person's own physiology. Reported side effects in trials included headache and some reports of mood changes; large-scale, long-term postmarket safety data specific to enclomiphene doesn't exist the way it does for testosterone injections, because enclomiphene was never approved and the ongoing use is compounded and off-label ^[3]. Monitoring matters either way. Anyone on either therapy should get baseline and follow-up labs: total and free testosterone, LH, FSH, estradiol, hematocrit or CBC, and a lipid panel are reasonable minimums, ideally through a prescriber who actually reviews the results rather than just refilling a script.

What does each option cost, in practical terms?

Pricing varies a lot by clinic, pharmacy, and dose, so treat these as ranges rather than quotes. Compounded enclomiphene typically runs somewhere in the neighborhood of $60 to $150 per month depending on dose and the pharmacy or telehealth provider, since pricing is set by individual compounding pharmacies and isn't standardized the way an FDA-approved drug's average wholesale price would be. Injectable testosterone cypionate itself is often cheap at the vial level, generic testosterone cypionate can run $30 to $80 a month in cash-pay terms at many pharmacies, but total TRT program cost usually runs higher once you add an hCG or hMG add-on to protect fertility/testicular size (often $50 to $150 a month extra), needles and supplies, and clinic or telehealth management fees, which can push all-in monthly costs into the $100 to $250-plus range depending on the provider. Neither of these numbers is something you should anchor to precisely, because neither enclomiphene nor most TRT protocols are FDA-price-listed commodities. Get an actual quote from the pharmacy or clinic before deciding on cost grounds alone.

Who tends to do better on enclomiphene versus injections?

This isn't a universal answer, it depends heavily on the underlying cause of low testosterone and what you actually want out of treatment. Men with secondary hypogonadism (the problem originates at the hypothalamus or pituitary, not the testicles) are the population enclomiphene trials actually studied, and it's the group where a SERM approach makes the most physiological sense, since the testicles themselves are functional and just need the LH/FSH signal restored ^[3]. Men actively trying to conceive, or who want to preserve that option without committing to hCG/hMG add-on therapy alongside TRT, are the clearest candidates for prioritizing enclomiphene or a fertility-preserving approach generally. This is also the group for whom testosterone injections are a genuinely poor fit if fertility matters in the near term, given the well-documented suppression of spermatogenesis ^[2]. Men with primary hypogonadism (testicular failure itself, Klinefelter syndrome, prior testicular injury) are generally not going to respond well to enclomiphene, because the problem isn't insufficient LH/FSH signal, it's that the testicles can't respond to the signal regardless of how strong it is. TRT is usually the more appropriate path here regardless of fertility considerations, since there often isn't much natural sperm production to preserve. Men who want the highest, most predictable testosterone numbers, and who aren't concerned about fertility (post-vasectomy, done having kids, no interest in future conception) often do fine on straightforward TRT and don't need the added complexity of a SERM.

Can you combine enclomiphene and testosterone, or switch between them?

Combining them doesn't make physiological sense in the way people sometimes hope. If you're injecting exogenous testosterone, your hypothalamus already sees plenty of testosterone circulating and will suppress GnRH regardless of what's happening at the estrogen receptor; enclomiphene's whole mechanism depends on the brain being convinced estrogen is low, and adding exogenous T undermines the endogenous production enclomiphene is trying to stimulate. In practice, men on TRT who want to protect fertility use hCG (which mimics LH directly at the testicle) or hMG, not enclomiphene, alongside their injections. Switching from TRT to enclomiphene is a real and fairly common scenario, usually for men who started injections, then decided they want children or don't like the injection routine, and want to come off exogenous testosterone. This transition needs real medical supervision: stopping TRT abruptly can leave a period where your own axis hasn't restarted yet and exogenous testosterone has cleared, producing a rough low-T stretch. Some protocols use enclomiphene (or clomiphene) specifically to help restart natural production during this transition. This is a use case worth discussing directly with a prescriber experienced in post-TRT recovery, not something to self-manage. Switching from enclomiphene to TRT is more straightforward mechanically since you're just adding exogenous hormone. The main consideration is that once on TRT you're back to the standard fertility-suppression profile described above.

What do you need to know about sourcing and injecting testosterone if you go that route?

If you and your prescriber land on injectable testosterone rather than enclomiphene, the practical mechanics differ enough from a daily oral to deserve their own homework. Reconstitution isn't usually the issue with pre-mixed testosterone cypionate/enanthate, but proper injection site rotation, needle gauge, and technique matter for absorption and comfort. See Enclomiphene Direct injection sites and Enclomiphene Direct how to inject for the general injection mechanics that carry over conceptually even when the compound differs. For those going the enclomiphene route instead, reconstitution and correct daily dosing are the more relevant skill, since compounded enclomiphene often ships as a powder or concentrate requiring proper mixing before use. That process, along with how long a typical course runs before reassessment, is covered in how to reconstitute Enclomiphene Direct and Enclomiphene Direct cycle length. Whichever path you take, the quality of the people managing your labs and dose adjustments matters more than the exact brand of vial. A prescriber who orders baseline labs, checks in at 6 to 12 weeks, and actually adjusts dose based on your numbers is worth more than a slightly cheaper source with no follow-up.

What would an experienced prescriber actually tell you to do?

If fertility matters to you right now or in the next couple of years, and your labs point to secondary hypogonadism, enclomiphene is the more defensible starting point, precisely because the mechanism keeps your own axis running. That's not a promise it will work as well as TRT at raising raw testosterone numbers for every man, some men simply respond better to direct hormone replacement, but it's the rational first try when preserving sperm production and testicular size is a real priority. If fertility isn't a near-term concern, if labs point to primary testicular failure, or if you've tried enclomiphene and your numbers or symptoms didn't improve enough, testosterone injections (with or without an hCG add-on if you want to keep some fertility option open) are a reasonable, well-studied, FDA-approved path. What's not reasonable: buying either one online without labs, without a prescriber reviewing your levels, or from a source that won't tell you which pharmacy is actually compounding or manufacturing the product. Given that compounded enclomiphene sits outside FDA approval, where you source it matters more, not less. A provider-reviewed process, where a licensed clinician actually looks at your labs and history before prescribing, and a named, accountable compounding pharmacy fills it, is the baseline you should expect. That's the model Enclomiphene Direct uses: a provider reviews your case, and the prescription is filled by a compounding pharmacy partner, not manufactured or compounded by Enclomiphene Direct itself. Either way, get labs before you start, get labs again 6 to 12 weeks in, and don't let anyone talk you into a protocol with no follow-up testing built in.

Frequently asked questions

Does enclomiphene lower sperm count like TRT does?

Trial data on enclomiphene showed it maintained LH, FSH, and semen parameters better than testosterone gel comparators, consistent with preserved fertility, unlike TRT which reliably suppresses sperm production by shutting down LH/FSH signaling ^[2][3]. But long-term, large-scale fertility outcome data specific to enclomiphene doesn't exist yet, so "preserved" is the well-supported expectation, not a guarantee.

Is enclomiphene the same thing as clomiphene or Clomid?

No. Clomiphene citrate (Clomid) is a mixture of two isomers, enclomiphene and zuclomiphene. Enclomiphene is the isomer believed to drive most of the LH/FSH-boosting effect; zuclomiphene has a longer half-life and different, weakly estrogenic activity. Enclomiphene-only products were developed specifically to isolate that effect and reduce estrogen-related side effects seen with clomiphene.

Why isn't enclomiphene FDA-approved if it's been studied in trials?

Enclomiphene citrate (as Androxal) went through phase 3 trials for secondary hypogonadism, but developer Repros Therapeutics discontinued the program after the FDA did not approve the New Drug Application in its submitted form ^[4]. No enclomiphene product currently holds FDA approval; what's sold today is compounded under a prescription.

What is compounded enclomiphene, and is it legal?

Compounded enclomiphene is made to order by a licensed compounding pharmacy under a prescription, rather than manufactured as an FDA-approved commercial drug. Pharmacy compounding is legal and regulated under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, but it isn't the same regulatory pathway or oversight level as an approved NDA ^[5].

Can you switch from testosterone injections to enclomiphene?

Yes, this is a common transition for men who want to stop TRT and restore natural production, often to pursue fertility. It requires medical supervision because stopping exogenous testosterone can create a temporary low-T window before the body's own axis restarts. Some prescribers use enclomiphene or clomiphene specifically to help kickstart that recovery.

Do enclomiphene and testosterone injections cost about the same?

Roughly comparable, though it varies by provider. Compounded enclomiphene often runs about $60 to $150 a month. Generic testosterone cypionate itself can be cheaper per vial, but total TRT program costs often land higher once you add fertility-preserving hCG, supplies, and clinic fees, frequently landing around $100 to $250 a month all-in.

Does enclomiphene cause the same side effects as testosterone injections?

They differ. TRT injections are linked to hematocrit/polycythemia risk and peak-trough mood or libido swings, with FDA labeling requiring hematocrit monitoring ^[6]. Enclomiphene trial data reported headache and some mood effects, without the same peak-trough injection pattern, but long-term postmarket safety data specific to enclomiphene isn't available since it was never FDA-approved.

Will enclomiphene raise testosterone as much as an injection?

Not necessarily to the same predictable degree. Injections directly add hormone, so dosing and resulting blood levels are fairly controllable. Enclomiphene raises testosterone by stimulating your own production via LH and FSH, so response depends on how well your pituitary and testicles respond, meaning results vary more between individuals.

Is enclomiphene a good option for men with primary testicular failure?

Generally not the best fit. Enclomiphene works by boosting LH and FSH signaling to functioning testicles. In primary hypogonadism (testicular failure itself, Klinefelter syndrome, or prior injury) the testicles often can't respond adequately to that signal regardless of how strong it is, so TRT is usually the more appropriate approach.

Do you need bloodwork before starting either enclomiphene or TRT?

Yes. Baseline labs (total and free testosterone, LH, FSH, estradiol, CBC/hematocrit) should be checked before starting either therapy, and again around 6 to 12 weeks in, regardless of which path you choose. Skipping monitoring is one of the most common and avoidable mistakes with both approaches.

Can you get pregnant while your partner is on enclomiphene versus TRT?

Mechanistically, enclomiphene is far less likely to impair sperm production than TRT, since it preserves LH/FSH signaling rather than suppressing it. But no enclomiphene product carries an FDA-approved fertility claim, and individual response varies, so couples actively trying to conceive should track semen parameters directly rather than assume fertility preservation.

How long does it take to see results from enclomiphene compared to injections?

Testosterone injections typically raise blood levels within days of the first dose since the hormone is added directly. Enclomiphene works more gradually, as it takes time for increased LH/FSH signaling to raise the testicles' own output, with meaningful lab changes often assessed around the 4 to 12 week mark in most protocols.

Sources

1. NIH StatPearls, Clomiphene: Clomiphene is a mixture of enclomiphene and zuclomiphene isomers; enclomiphene is the anti-estrogenic trans-isomer that drives LH/FSH stimulation at the hypothalamus
2. WHO Task Force multinational trial, Fertility and Sterility: Injectable testosterone reliably suppresses spermatogenesis, producing azoospermia or severe oligozoospermia in the large majority of men studied
3. Wiehle et al., enclomiphene citrate phase 3 trial data, Journal of Sexual Medicine: Enclomiphene citrate raised testosterone into normal range while maintaining LH, FSH, and sperm parameters better than topical testosterone comparators in secondary hypogonadism
4. Repros Therapeutics SEC/press disclosure on Androxal FDA response: Enclomiphene citrate (Androxal) did not receive FDA approval and the development program was discontinued
5. 21 U.S.C. 353a, Pharmacy Compounding: Pharmacy compounding is regulated under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, distinct from the approval pathway for manufactured drugs